Sign up to save your podcasts
Or
Share JAMA Dermatology : Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Dermatology : Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma
Interview with Ivo Abraham, PhD, author of Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Ivo Abraham, PhD, author of Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma
More shows like JAMA Network
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
321 Listeners
AFP: American Family Physician Podcast
694 Listeners
JAMA Clinical Reviews
496 Listeners
Medicine and Science from The BMJ
37 Listeners
Diabetes Core Update
101 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,333 Listeners
JAMA Pediatrics Editors' Summary
38 Listeners
JAMA Neurology Author Interviews
13 Listeners
JAMA Dermatology Author Interviews
16 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Otolaryngology–Head Neck Surgery Author Interviews
6 Listeners
Core IM | Internal Medicine Podcast
1,154 Listeners
JAMAevidence The Rational Clinical Examination
29 Listeners
Annals On Call Podcast
195 Listeners
JAMA Medical News
90 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Cardionerds: A Cardiology Podcast
433 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
The Curious Clinicians
369 Listeners
NEJM AI Grand Rounds
58 Listeners